Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCR in previously untreated CLL
NCT00541034Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 2005
- Primary completion
- Jan 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pentostatin in chronic lymphocytic leukemia (CLL), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Overall Objective Response at 2 years. Started May 2005; status: completed.
02
Drugs
pentostatin
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00541034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541034.